OptimizeRx Grows Patient Communication Platform with RMDY Acquisition

OptimizeRx Grows Patient Communication Platform with RMDY Acquisition

OptimizeRx (NYSE: OPRX), a digital patient communication company, ramped up its platform last week with the acquisition of RMDY Health for $16 million. RMDY offers a SaaS platform that provides a complete digital framework to help life science and healthcare stakeholders design and launch their own white-label collaborative digital care and patient support programs. The company’s web and mobile platform supports a wide range of digital therapeutic initiatives, with a focus on care and chronic disease management, among others. For 2019, the company has an estimated annual revenue of $3 million. The acquisition adds three new client segments to OptimizeRx’s existing patient... Read More »